Comparison of the C2A domain of synaptotagmin-I and annexin-V as probes for detecting cell death

Bioconjugate Chemistry

Volumn 21, Issue 5, 2010, Pages 884-891

  Alam, Israt S ^b   Neves, Andre A ^b   Witney, Timothy H ^a   Boren, Joan ^b   Brindle, Kevin M ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; FLUORESCENT DYE; LIPOCORTIN 5; SYNAPTOTAGMIN I;

APOPTOSIS; ARTICLE; BREAST CANCER; C2A DOMAIN; CANCER CELL; CELL DEATH; CONTROLLED STUDY; DIAGNOSTIC IMAGING; HUMAN; HUMAN CELL CULTURE; IN VITRO STUDY; LYMPHOMA; MUTAGENESIS; NECROSIS; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN;

MURINAE;

EID: 77952578519     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc9004415     Document Type: Article

References (44)

1. Blankenberg, F. G. (2008) In vivo detection of apoptosis J. Nucl. Med. 49, 81S-95S
2. Brindle, K. (2008) New approaches for imaging tumour responses to treatment Nat. Rev. Cancer 8, 1-14
3. Chang, J., Ormerod, M., Powles, T. J., Allred, D. C., Ashley, S. E., and Dowsett, M. (2000) Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma Cancer 2000, 2145-2152
4. Buchholz, T. A., Davis, D. W., McConkey, D. J., Symmans, W. F., Valero, V., Jhingran, A., Tucker, S. L., Pusztai, L., Cristofanilli, M., Esteva, F. J., Hortobagyi, G. N., and Sahin, A. A. (2003) Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy Cancer J. 9, 33-41
5. Savill, J., Fadok, V., Henson, P., and Haslett, C. (1993) Phagocyte recognition of cells undergoing apoptosis Immunol. Today 14, 131-136
6. Hofstra, L., Liem, I. H., Dumont, E. A., Boersma, H., van Heerde, W. L., Doevendans, P. A., DeMuinck, E., Wellens, H. J. J., Kemerink, G. J., Reutelingsperger, C. P. M., and Heidendal, G. A. (2000) Visualisation of cell death in vivo in patients with acute myocardial infarction Lancet 356, 209-212
7. (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis Clin. Cancer Res. 8, 2766-2774
8. Boersma, H. H., Kietselaer, B. L., Stolk, L. M., Bennaghmouch, A., Hofstra, L., Narula, J., Heidendal, G. A., and Reutelingsperger, C. P. (2005) Past, present, and future of annexin A5: from protein discovery to clinical applications J. Nucl. Med. 46, 2035-2050
9. Kemerink, G. J., Boersma, H. H., Thimister, P. W. L., Hofstra, L., Liem, I. H., Pakbiers, M. T. W., Janssen, D., Reutelingsperger, C. P. M., and Heidendal, G. A. K. (2001) Biodistribution and dosimetry of Tc-99m-BTAP-annexin- V in humans Eur. J. Nuc. Med. 28, 1373-1378
10. Boersma, H. H., Liem, I. H., Kemerink, G. J., Thimister, P. W. L., Hofstra, L., Stolk, L. M. L., van Heerde, W. L., Pakbiers, M. T. W., Janssen, D., Beysens, A. J., Reutelingsperger, C. P. M., and Heidendal, G. A. K. (2003) Comparison between human pharmacokinetics and imaging properties of two conjugation methods for Tc-99m-Annexin A5 Brit. J. Radiol. 76, 553-560
11. Davletov, B. A. and Sudhof, T. C. (1993) A single C2 domain from synaptotagmin I is sufficient for high affinity Ca2+/phospholipid binding J. Biol. Chem. 268, 26386-26390
12. Sudhof, T. C., De Camilli, P., Niemann, H., and Jahn, R. (1993) Membrane fusion machinery: insights from synaptic proteins Cell 75, 1-4
13. Zhao, M., Beauregard, D. A., Loizou, L., Davletov, B., and Brindle, K. M. (2001) Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent Nat. Med. 7, 1241-1244
14. Zhao, M., Zhu, X., Ji, S., Zhou, J., Ozker, K. S., Fang, W., Molthen, R. C., and Hellman, R. S. (2006) 99mTc-labeled C2A domain of synaptotagmin I as a target-specific molecular probe for noninvasive imaging of acute myocardial infarction J. Nucl. Med. 47, 1367-1374
15. Krishnan, A. S., Neves, A. A., de Backer, M. M., Hu, D.-E., Davletov, B., Kettunen, M. I., and Brindle, K. M. (2008) Detection of cell death in tumors using MRI and a gadolinium-based targeted contrast agent Radiology 246, 854-862
16. Neves, A. A., Krishnan, A. S., Kettunen, M. I., Hu, D.-E., deBacker, M. M., Davletov, B., and Brindle, K. M. (2007) A paramagnetic nanoprobe to detect tumor cell death using magnetic resonance imaging Nano Lett. 7, 1419-1423
17. Sims, J. L., Berger, S. J., and Berger, N. A. (1983) Poly(ADP-ribose) polymerase inhibitors preserve nicotinamide adenine dinucleotide and adenosine 5′-triphosphate pools in DNA-damaged cells: mechanism of stimulation of unscheduled DNA synthesis Biochemistry 22, 5188-5194
18. Witney, T. H., Kettunen, M. I., Day, S. E., Hu, D. E., Neves, A. A., Gallagher, F. A., Fulton, S. M., and Brindle, K. M. (2009) A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized C-13-labeled pyruvate utilization as methods for detecting tumor response to treatment Neoplasia 6, 574-582
19. Krysko, D. V., Berghe, T. V., DHerde, K., and Vandenabeele, P. (2008) Apoptosis and necrosis: detection, discrimination and phagocytosis Methods 44, 205-221
20. Primeau, A. J., Rendon, A., Hedley, D., Lilge, L., and Tannock, I. F. (2005) The distribution of the anticancer drug doxorubicin in relation to blood vessels in solid tumors Clin. Cancer Res. 11, 8782-8788
21. Almeida, P. F. F., Sohma, H., Rasch, K. A., Wieser, C. M., and Hinderliter, A. (2005) Allosterism in membrane binding: A common motif of the annexins? Biochemistry 44, 10905-10913
22. 2+ binding to the C(2)A domain of synaptotagmin 1 J. Neurosci. 22, 8438-8446
23. Vermes, I., Haanen, C., Steffens-Nakken, H., and Reutelingsperger, C. P. (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V J. Immunol. Methods 184, 39-51
24. van Genderen, H., Kenis, H., Lux, P., Ungethum, L., Maassen, C., Deckers, N., Narula, J., Hofstra, L., and Reutelingsperger, C. (2006) In vitro measurement of cell death with the annexin A5 affinity assay Nat. Protoc. 1, 363-367
25. 64Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V Eur. J. Nucl. Med. Mol. Imaging 34, 247-258
26. Keen, H. G., Dekker, B. A., Disley, L., Hastings, D., Lyons, S., Reader, A. J., Ottewell, P., Watson, A., and Zweit, J. (2005) Imaging apoptosis in vivo using I-124-annexin V and PET Nucl. Med. Biol. 32, 395-402
27. Petrovsky, A., Schellenberger, E., Josephson, L., Weissleder, R., and Bogdanov, A. (2003) Near-infrared fluorescent imaging of tumor apoptosis Cancer Res. 63, 1936-1942
28. Schellenberger, E. A., Bogdanov, A., Jr., Petrovsky, A., Ntziachristos, V., Weissleder, R., and Josephson, L. (2003) Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy Neoplasia 5, 187-192
29. Yagle, K. J., Eary, J. F., Tait, J. F., Grierson, J. R., Link, J. M., Lewellen, B., Gibson, D. F., and Krohn, K. A. (2005) Evaluation of F-18-annexin V as a PET imaging agent in an animal model of apoptosis J. Nucl. Med. 46, 658-666
30. Schellenberger, E. A., Bogdanov, A., Jr., Hogemann, D., Tait, J., Weissleder, R., and Josephson, L. (2002) Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI Mol. Imaging 1, 102-107
31. Sutton, R. B., Davletov, B. A., Berghuis, A. M., Sudhof, T. C., and Sprang, S. R. (1995) Structure of the first C2 domain of synaptotagmin I: a novel Ca2+/phospholipid-binding fold Cell 80, 929-938
32. Jung, H. I., Kettunen, M. I., Davletov, B., and Brindle, K. M. (2004) Detection of apoptosis using the C2A domain of synaptotagmin I Bioconjugate Chem. 15, 983-987
33. Borisenko, G. G., Matsura, T., Liu, S. X., Tyurin, V. A., Jianfei, J., Serinkan, F. B., and Kagan, V. E. (2003) Macrophage recognition of externalized phosphatidylserine and phagocytosis of apoptotic Jurkat cells - existence of a threshold Arch. Biochem. Biophys. 413, 41-52
34. Smolewski, P., Grabarek, J., Halicka, D. H., and Darzynkiewicz, Z. (2002) Assay of caspase activation in situ combined with probing plasma membrane integrity to detect three distinct stages of apoptosis J. Immunol. Methods 265, 111-121
35. Pozarowski, P., Huang, X., Halicka, D. H., Lee, B., Johnson, G., and Darzynkiewicz, Z. (2003) Interactions of fluorochrome-labeled caspase inhibitors with apoptotic cells: a caution in data interpretation Cytometry, Part A 55A, 50-60
36. Kuo, W. W., Herrick, D. Z., Ellena, J. F., and Cafiso, D. S. (2009) The calcium-dependent and calcium-independent membrane binding of Synaptotagmin 1: Two modes of C2B binding J. Mol. Biol. 387, 284-294
37. Emoto, K., Toyama-Sorimachi, N., Karasuyama, H., Inoue, K., and Umeda, M. (1997) Exposure of phosphatidylethanolamine on the surface of apoptotic cells Exp. Cell Res. 232, 430-434
38. 2+ induce a conformational change? Biochemistry 37, 16106-16115
39. Liemann, S. and Huber, R. (1997) Three-dimensional structure of annexins Cell. Mol. Life Sci. 53, 516-521
40. Silvestro, L. and Axelsen, P. H. (1999) Fourier transform infrared linked analysis of conformational changes in annexin V upon membrane binding Biochemistry 38, 113-121
41. 2+-induced conformational-changes Science 261, 1321-1324
42. Concha, N. O., Head, J. F., Kaetzel, M. A., Dedman, J. R., and Seaton, B. A. (1992) Annexin-V forms calcium-dependent trimeric units on phospholipid-vesicles FEBS Lett. 314, 159-162
43. Appelt, U., Sheriff, A., Gaipl, U. S., Kalden, J. R., Voll, R. E., and Herrmann, M. (2005) Viable, apoptotic and necrotic monocytes expose phosphatidylserine: cooperative binding of the ligand Annexin V to dying but not viable cells and implications for PS-dependent clearance Cell Death Differ. 12, 194-196
44. Tait, J. F. and Gibson, D. (1992) Phospholipid binding of annexin-V-effects of calcium and membrane phosphatidylserine content Arch. Biochem. Biophys. 298, 187-191